Skip to main content

Advertisement

Table 3 Average ratings (standard deviation) on PRECIS and RE-AIM domains: scores by study

From: How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research

Domains POWER mean (SD) eHealth mean (SD) MOHR mean (SD)
Participant Eligibility Criteria 1.8 (0.6) 3.2 (0.7) 3.0 (0)
Experimental Intervention Flexibility 1.6 (0.9) 2.8 (0.9) 4.0 (0)
Practitioner Expertise (Experimental) 1.6 (0.9) 2.7 (0.9) 3.3 (0.6)
Comparison Intervention Flexibility 2.9 (1.2) 2.9 (1.2) 4.0 (0)
Practitioner Expertise (Comparison) 2.5 (1.3) 2.8 (1.0) 4.0 (0)
Follow-up Intensity 1.4 (1.1) 3.2 (0.9) 3.0 (0)
Primary Trial Outcome 2.4 (0.7) 2.9 (0.7) 3.3 (0.6)
Participant Compliance 1.2 (0.8) 3.2 (0.8) 2.7 (0.6)
Practitioner Adherence to Protocol 1.7 (0.9) 3.6 (1.0) 3.3 (0.6)
Analysis of Primary Outcome 2.0 (1.4) 3.5 (0.8) 3.3 (0.6)
Participant Representativeness 2.3 (0.8) 2.5 (0.7) 3.3 (0.6)
Setting Representativeness 2.1 (1.3) 2.8 (1.0) 3.0 (0)
Adaptation/Change 1.4 (1.0) 1.5 (0.6) 3.7 (0.6)
Sustainability 1.4 (1.0) 1.6 (0.7) 2.0 (0)
Costs/Feasibility of Treatment 2.0 (1.2) 1.6 (0.7) 4.0 (0)
  1. Note: PRECIS: Pragmatic Explanatory Continuum Indicator Summary. RE-AIM: Reach, Effectiveness, Adoption, Implementation, and Maintenance Framework. POWER Trials = Practice-Based Opportunities for Weight Reduction Trials Collaborative Research Group; eHealth Reviews = Systematic Review of eHealth Cancer Prevention and Control Interventions; MOHR = My Own Health Report. To make ratings comparable, the ratings were converted so that for all studies, scoring continuum: 1 = Explanatory, 5 = Pragmatic.